Regulation of apoptosis by alternative pre-mRNA splicing.
暂无分享,去创建一个
[1] K. Schulze-Osthoff,et al. Non-apoptotic functions of caspases in cellular proliferation and differentiation. , 2003, Biochemical pharmacology.
[2] M. Beato,et al. Promoter Choice Influences Alternative Splicing and Determines the Balance of Isoforms Expressed from the Mousebcl-X Gene* , 2001, The Journal of Biological Chemistry.
[3] M. P. Holloway,et al. Survivin splice variants regulate the balance between proliferation and cell death , 2005, Oncogene.
[4] C. Thompson,et al. bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death , 1993, Cell.
[5] A. Godzik,et al. The Domains of Apoptosis: A Genomics Perspective , 2004, Science's STKE.
[6] Y. Rao,et al. Regulation of Ich-1 pre-mRNA alternative splicing and apoptosis by mammalian splicing factors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[7] R. Testi,et al. Fas/Apo-1 (CD95) receptor lacking the intracytoplasmic signaling domain protects tumor cells from Fas-mediated apoptosis. , 1996, Journal of immunology.
[8] J. Côté,et al. Polypyrimidine Track-binding Protein Binding Downstream of Caspase-2 Alternative Exon 9 Represses Its Inclusion* , 2001, The Journal of Biological Chemistry.
[9] H. Lodish,et al. Tumor Necrosis Factor Receptor (TNFR)-associated Factor 2A (TRAF2A), a TRAF2 Splice Variant with an Extended RING Finger Domain That Inhibits TNFR2-mediated NF-κB Activation* , 1998, The Journal of Biological Chemistry.
[10] Ingo Schmitz,et al. Differential Modulation of Apoptosis Sensitivity in CD95 Type I and Type II Cells* , 1999, The Journal of Biological Chemistry.
[11] Xin Lu,et al. Live or let die: the cell's response to p53 , 2002, Nature Reviews Cancer.
[12] D. Reinberg,et al. ASAP, a Novel Protein Complex Involved in RNA Processing and Apoptosis , 2003, Molecular and Cellular Biology.
[13] P. Loyer,et al. The RNP protein, RNPS1, associates with specific isoforms of the p34cdc2-related PITSLRE protein kinase in vivo. , 1998, Journal of cell science.
[14] P. Krammer,et al. Resistance of Short Term Activated T Cells to CD95-Mediated Apoptosis Correlates with De Novo Protein Synthesis of c-FLIPshort1 , 2004, The Journal of Immunology.
[15] G. Melino,et al. p73: Friend or foe in tumorigenesis , 2002, Nature Reviews Cancer.
[16] J. Côté,et al. Caspase-2 pre-mRNA alternative splicing: Identification of an intronic element containing a decoy 3' acceptor site. , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[17] M. Garcia-Blanco,et al. Co-transcriptional splicing of pre-messenger RNAs: considerations for the mechanism of alternative splicing. , 2001, Gene.
[18] S. Edwards,et al. Alternative splicing of Bcl-2-related genes: functional consequences and potential therapeutic applications , 2004, Cellular and Molecular Life Sciences CMLS.
[19] Shelly C. Lu,et al. S‐adenosylmethionine and its metabolite induce apoptosis in HepG2 cells: Role of protein phosphatase 1 and Bcl‐xS , 2004, Hepatology.
[20] E V Koonin,et al. Apoptotic molecular machinery: vastly increased complexity in vertebrates revealed by genome comparisons. , 2001, Science.
[21] W. Earnshaw,et al. Differential localization of ICAD-L and ICAD-S in cells due to removal of a C-terminal NLS from ICAD-L by alternative splicing. , 2000, Experimental cell research.
[22] Y. Hannun,et al. FAS Activation Induces Dephosphorylation of SR Proteins , 2001, The Journal of Biological Chemistry.
[23] M. Bourgeade,et al. B Cell Receptor-Mediated Apoptosis of Human Lymphocytes Is Associated with a New Regulatory Pathway of Bim Isoform Expression1 , 2004, The Journal of Immunology.
[24] D. Altieri. Validating survivin as a cancer therapeutic target , 2003, Nature Reviews Cancer.
[25] Jerry M. Adams,et al. Ways of dying: multiple pathways to apoptosis. , 2003, Genes & development.
[26] G. Matlashewski,et al. Regulation of Human p53 Activity and Cell Localization by Alternative Splicing , 2004, Molecular and Cellular Biology.
[27] J. Valcárcel,et al. The splicing regulator TIA‐1 interacts with U1‐C to promote U1 snRNP recruitment to 5′ splice sites , 2002, The EMBO journal.
[28] M. Saarma,et al. Neuron-specific Bcl-2 Homology 3 Domain-only Splice Variant of Bak Is Anti-apoptotic in Neurons, but Pro-apoptotic in Non-neuronal Cells* , 2001, The Journal of Biological Chemistry.
[29] J. Bell,et al. LARD: a new lymphoid-specific death domain containing receptor regulated by alternative pre-mRNA splicing. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[30] J. Gottesfeld,et al. Cyclin L Is an RS Domain Protein Involved in Pre-mRNA Splicing* , 2002, The Journal of Biological Chemistry.
[31] S H Kaufmann,et al. Mammalian caspases: structure, activation, substrates, and functions during apoptosis. , 1999, Annual review of biochemistry.
[32] G. Núñez,et al. Expression and Functional Analysis of Apaf-1 Isoforms , 2000, The Journal of Biological Chemistry.
[33] H. Horvitz,et al. The genetics of programmed cell death in the nematode Caenorhabditis elegans. , 1994, Cold Spring Harbor symposia on quantitative biology.
[34] A. Mayeda,et al. CDK11 Complexes Promote Pre-mRNA Splicing* , 2003, The Journal of Biological Chemistry.
[35] J. Tschopp,et al. Regulation of Interleukin-1- and Lipopolysaccharide-Induced NF-κB Activation by Alternative Splicing of MyD88 , 2002, Current Biology.
[36] C. Suschek,et al. Differential subcellular localization of functionally divergent survivin splice variants , 2002, Cell Death and Differentiation.
[37] P. Krammer,et al. FLICE-Inhibitory Proteins: Regulators of Death Receptor-Mediated Apoptosis , 2001, Molecular and Cellular Biology.
[38] J. Stévenin,et al. TIA-1 and TIAR Activate Splicing of Alternative Exons with Weak 5′ Splice Sites followed by a U-rich Stretch on Their Own Pre-mRNAs* , 2001, The Journal of Biological Chemistry.
[39] S. Dower,et al. Three Novel Bid Proteins Generated by Alternative Splicing of the Human Bid Gene* , 2004, Journal of Biological Chemistry.
[40] T. Cooper,et al. Pre-mRNA splicing and human disease. , 2003, Genes & development.
[41] Shizuo Akira,et al. Toll-like Receptor Signaling* , 2003, Journal of Biological Chemistry.
[42] H. Lou,et al. U1 snRNP-Dependent Function of TIAR in the Regulation of Alternative RNA Processing of the Human Calcitonin/CGRP Pre-mRNA , 2003, Molecular and Cellular Biology.
[43] D. Cooper,et al. The mutational spectrum of single base-pair substitutions in mRNA splice junctions of human genes: Causes and consequences , 1992, Human Genetics.
[44] K. Schulze-Osthoff,et al. The role of caspases in development, immunity, and apoptotic signal transduction: lessons from knockout mice. , 1999, Immunity.
[45] B. Graveley. Sorting out the complexity of SR protein functions. , 2000, RNA.
[46] John Calvin Reed,et al. Immunohistochemical analysis of in vivo patterns of Bcl-X expression. , 1994, Cancer research.
[47] Jane Y. Wu,et al. Alternative pre-mRNA splicing and regulation of programmed cell death. , 2003, Progress in molecular and subcellular biology.
[48] G. Pruijn,et al. The fate of U1 snRNP during anti-Fas induced apoptosis: specific cleavage of the U1 snRNA molecule , 2000, Cell Death and Differentiation.
[49] D. K. Miller,et al. Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. , 1994, The Journal of biological chemistry.
[50] D. Green,et al. The Pathophysiology of Mitochondrial Cell Death , 2004, Science.
[51] C. Guthrie,et al. Mechanical Devices of the Spliceosome: Motors, Clocks, Springs, and Things , 1998, Cell.
[52] Steven P. Gygi,et al. Comprehensive proteomic analysis of the human spliceosome , 2002, Nature.
[53] J Vandekerckhove,et al. Nuclear relocalization of the pre-mRNA splicing factor PSF during apoptosis involves hyperphosphorylation, masking of antigenic epitopes, and changes in protein interactions. , 2001, Molecular biology of the cell.
[54] F. Li,et al. Role of survivin and its splice variants in tumorigenesis , 2004, British Journal of Cancer.
[55] C. Chalfant,et al. Identification of Two RNA cis-Elements That Function to Regulate the 5′ Splice Site Selection of Bcl-x Pre-mRNA in Response to Ceramide* , 2004, Journal of Biological Chemistry.
[56] J. E. Mermoud,et al. Regulation of mammalian spliceosome assembly by a protein phosphorylation mechanism. , 1994, The EMBO journal.
[57] A. Porter,et al. Molecular Cloning and Characterization of Two Novel Pro-apoptotic Isoforms of Caspase-10* , 1999, The Journal of Biological Chemistry.
[58] J. Valcárcel,et al. Molecular mechanisms of gene expression regulation by the apoptosis-promoting protein TIA-1 , 2001, Apoptosis.
[59] Bosiljka Tasic,et al. Alternative pre-mRNA splicing and proteome expansion in metazoans , 2002, Nature.
[60] P. Anderson,et al. Human Autoimmune Sera as Molecular Probes for the Identification of an Autoantigen Kinase Signaling Pathway , 2002, The Journal of experimental medicine.
[61] K. Schulze-Osthoff,et al. Many cuts to ruin: a comprehensive update of caspase substrates , 2003, Cell Death and Differentiation.
[62] D. Seol,et al. A Caspase-9 Variant Missing the Catalytic Site Is an Endogenous Inhibitor of Apoptosis* , 1999, The Journal of Biological Chemistry.
[63] H. Horvitz,et al. An Alternatively Spliced C. elegans ced-4 RNA Encodes a Novel Cell Death Inhibitor , 1996, Cell.
[64] T. Misteli,et al. Serine/threonine phosphatase 1 modulates the subnuclear distribution of pre-mRNA splicing factors. , 1996, Molecular biology of the cell.
[65] Nan Li,et al. Cyclin L2, a Novel RNA Polymerase II-associated Cyclin, Is Involved in Pre-mRNA Splicing and Induces Apoptosis of Human Hepatocellular Carcinoma Cells* , 2004, Journal of Biological Chemistry.
[66] Y. Hannun,et al. De Novo Ceramide Regulates the Alternative Splicing of Caspase 9 and Bcl-x in A549 Lung Adenocarcinoma Cells , 2002, The Journal of Biological Chemistry.
[67] A. Strasser,et al. Bim: a novel member of the Bcl‐2 family that promotes apoptosis , 1998, The EMBO journal.
[68] J. Manley,et al. SR proteins and splicing control. , 1996, Genes & development.
[69] D. Hancock,et al. Identification of Novel Isoforms of the BH3 Domain Protein Bim Which Directly Activate Bax To Trigger Apoptosis , 2002, Molecular and Cellular Biology.
[70] C. Riccardi,et al. Cloning and expression of a short Fas ligand: A new alternatively spliced product of the mouse Fas ligand gene. , 1999, Blood.
[71] L. Cantley,et al. Use of RNA Interference-mediated Gene Silencing and Adenoviral Overexpression to Elucidate the Roles of AKT/Protein Kinase B Isoforms in Insulin Actions* , 2003, Journal of Biological Chemistry.
[72] C. Rudin,et al. Apoptosis and disease: regulation and clinical relevance of programmed cell death. , 1997, Annual review of medicine.
[73] N. Imamoto,et al. Acinus is a caspase-3-activated protein required for apoptotic chromatin condensation , 1999, Nature.
[74] M. Beato,et al. Steroid Hormones Induce bcl-X Gene Expression through Direct Activation of Distal Promoter P4* , 2004, Journal of Biological Chemistry.
[75] D. Ferrari,et al. Apoptosis signaling by death receptors. , 1998, European journal of biochemistry.
[76] S. Elledge,et al. Fas-activated serine/threonine kinase (FAST) phosphorylates TIA-1 during Fas-mediated apoptosis , 1995, The Journal of experimental medicine.
[77] Shizuo Akira,et al. Toll-like receptor signalling , 2004, Nature Reviews Immunology.
[78] R. Kole,et al. Therapeutic potential of antisense oligonucleotides as modulators of alternative splicing. , 2003, The Journal of clinical investigation.
[79] Pierre Hainaut,et al. p53 protein variants: structural and functional similarities with p63 and p73 isoforms , 2004, Oncogene.
[80] G. Fiucci,et al. Three functional soluble forms of the human apoptosis-inducing Fas molecule are produced by alternative splicing. , 1995, Journal of immunology.
[81] P. Anderson,et al. Association of Phosphorylated Serine/Arginine (SR) Splicing Factors With The U1–Small Ribonucleoprotein (snRNP) Autoantigen Complex Accompanies Apoptotic Cell Death , 1998, The Journal of experimental medicine.
[82] J. Comella,et al. Characterization of splice variants of human caspase‐activated DNase with CIDE‐N structure and function , 2004, FEBS letters.
[83] O. Janssen,et al. CD95 ligand - death factor and costimulatory molecule? , 2003, Cell Death and Differentiation.
[84] Christopher J. Lee,et al. Alternative splicing in the human, mouse and rat genomes is associated with an increased frequency of exon creation and/or loss , 2003, Nature Genetics.
[85] Matthew J. Brauer,et al. Protection from Fas-mediated apoptosis by a soluble form of the Fas molecule. , 1994, Science.
[86] P. Krammer,et al. c-FLIPR, a New Regulator of Death Receptor-induced Apoptosis* , 2005, Journal of Biological Chemistry.
[87] I. N. Crispe,et al. A naturally occurring soluble isoform of murine Fas generated by alternative splicing , 1995, The Journal of experimental medicine.
[88] D. Brow,et al. Allosteric cascade of spliceosome activation. , 2002, Annual review of genetics.
[89] Brenton R Graveley,et al. Exon-specific RNAi: a tool for dissecting the functional relevance of alternative splicing. , 2002, RNA.
[90] L. Bracco,et al. The relevance of alternative RNA splicing to pharmacogenomics. , 2003, Trends in biotechnology.
[91] Xiaolu Yang,et al. c‐FLIPL is a dual function regulator for caspase‐8 activation and CD95‐mediated apoptosis , 2002, The EMBO journal.
[92] J. Wyatt,et al. Induction of endogenous Bcl-xS through the control of Bcl-x pre-mRNA splicing by antisense oligonucleotides , 1999, Nature Biotechnology.
[93] Ying Jin,et al. Smac3, a Novel Smac/DIABLO Splicing Variant, Attenuates the Stability and Apoptosis-inhibiting Activity of X-linked Inhibitor of Apoptosis Protein* , 2003, Journal of Biological Chemistry.
[94] Sherif Abou Elela,et al. Reprogramming Alternative Pre-messenger RNA Splicing through the Use of Protein-binding Antisense Oligonucleotides* , 2003, Journal of Biological Chemistry.
[95] A. Strasser,et al. The proapoptotic activity of the Bcl-2 family member Bim is regulated by interaction with the dynein motor complex. , 1999, Molecular cell.
[96] L. Wang,et al. Ich-1, an Ice/ced-3-related gene, encodes both positive and negative regulators of programmed cell death , 1994, Cell.
[97] J. Tschopp,et al. The Long Form of FLIP Is an Activator of Caspase-8 at the Fas Death-inducing Signaling Complex* , 2002, The Journal of Biological Chemistry.
[98] S. Lederman,et al. TRAF-3 mRNA splice-deletion variants encode isoforms that induce NF-kappaB activation. , 1999, Molecular immunology.
[99] K. Burns,et al. Inhibition of Interleukin 1 Receptor/Toll-like Receptor Signaling through the Alternatively Spliced, Short Form of MyD88 Is Due to Its Failure to Recruit IRAK-4 , 2003, The Journal of experimental medicine.
[100] D. Black. Mechanisms of alternative pre-messenger RNA splicing. , 2003, Annual review of biochemistry.
[101] B. Aggarwal. Signalling pathways of the TNF superfamily: a double-edged sword , 2003, Nature Reviews Immunology.